OBJECTIVE: To validate a disease-specific quality-of-life instrument--the Skin Cancer Index--intended to measure quality-of-life issues relevant to patients with nonmelanoma skin cancer. METHODS: Internal reliability, convergent and divergent validity with existing scales, and factor analyses were performed in a cross-sectional study of 211 patients presenting with cervicofacial nonmelanoma skin cancer to a dermatologic surgery clinic. RESULTS: Factor analyses of the Skin Cancer Index confirmed a multidimensional scale with 3 distinct subscales-emotional, social, and appearance. Excellent internal validity of the 3 subscales was demonstrated. Substantial evidence was observed for convergent validity with the Dermatology Life Quality Index, Rosenberg Self-Esteem Scale, Lerman's Cancer Worry Scale, and Medical Outcomes Survey Short-Form 12 domains for vitality, emotion, social function, and mental health. CONCLUSIONS: These findings validate a new disease-specific quality-of-life instrument for patients with cervicofacial nonmelanoma skin cancer. Studies on the responsiveness of the Skin Cancer Index to clinical intervention are currently under way.
OBJECTIVE: To validate a disease-specific quality-of-life instrument--the Skin Cancer Index--intended to measure quality-of-life issues relevant to patients with nonmelanoma skin cancer. METHODS: Internal reliability, convergent and divergent validity with existing scales, and factor analyses were performed in a cross-sectional study of 211 patients presenting with cervicofacial nonmelanoma skin cancer to a dermatologic surgery clinic. RESULTS: Factor analyses of the Skin Cancer Index confirmed a multidimensional scale with 3 distinct subscales-emotional, social, and appearance. Excellent internal validity of the 3 subscales was demonstrated. Substantial evidence was observed for convergent validity with the Dermatology Life Quality Index, Rosenberg Self-Esteem Scale, Lerman's Cancer Worry Scale, and Medical Outcomes Survey Short-Form 12 domains for vitality, emotion, social function, and mental health. CONCLUSIONS: These findings validate a new disease-specific quality-of-life instrument for patients with cervicofacial nonmelanoma skin cancer. Studies on the responsiveness of the Skin Cancer Index to clinical intervention are currently under way.
Authors: John S Rhee; B Alex Matthews; Marcy Neuburg; Timothy L Smith; Mary Burzynski; Ann B Nattinger Journal: Dermatol Surg Date: 2004-04 Impact factor: 3.398
Authors: John S Rhee; B Alex Matthews; Marcy Neuburg; Timothy L Smith; Mary Burzynski; Ann B Nattinger Journal: Arch Otolaryngol Head Neck Surg Date: 2004-02
Authors: John S Rhee; Fausto R Loberiza; B Alex Matthews; Marcy Neuburg; Timothy L Smith; Mary Burzynski Journal: Laryngoscope Date: 2003-02 Impact factor: 3.325
Authors: Shoko Mori; Nina R Blank; Karen L Connolly; Stephen W Dusza; Kishwer S Nehal; Anthony M Rossi; Erica H Lee Journal: JAMA Dermatol Date: 2019-01-01 Impact factor: 10.282
Authors: John S Rhee; B Alex Matthews; Marcy Neuburg; Brent R Logan; Mary Burzynski; Ann B Nattinger Journal: Laryngoscope Date: 2007-03 Impact factor: 3.325
Authors: Paula Curitiba Maciel; Joel Veiga-Filho; Marcelo Prado Carvalho; Fernando Elias Martins Fonseca; Lydia Masako Ferreira; Daniela Francescato Veiga Journal: An Bras Dermatol Date: 2014 Jul-Aug Impact factor: 1.896